Genevant Sciences Revenue

Biotechnology Research • Vancouver, British Columbia, Canada • 51-100 Employees

Genevant Sciences revenue & valuation

Annual revenue	$4,705,525
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$15,100,000
Total funding	No funding

Key Contacts at Genevant Sciences

Xin Ye

Director, Extrahepatic Delivery

Owen Daly

Director, Technology Development

Mathew Bakatsis

Director, Head Of Quality Assurance

Richard Holland Phd

Senior Director Of Chemistry Technology Development

Stephan Kutik

Senior Director, Intellectual Property

Ed Yaworski

Chief Technology Officer

Steve Reid

Senior Director, Pharmaceutical Development

Sunny Jeng

Director

Kevin Mcclintock

Director In Vivo Resources

Pomy Bhatti

Director Of It

Company overview

Headquarters	887 Great Northern Way, Unit 155, Vancouver, British Columbia V5T, CA
Website	genevant.com
SIC	873
Keywords	Research, RNA, Drug Development, Biologics, Sirna, Rare Disease, Drug Delivery, Rnai, LNP, Liver Disease, Oligonucleotides, Formulations, IND, Gene Editing, Mrna, Extrahepatic, Lnp Delivery, Ligand Conjugates, Lipid Nanoparticles
Employees	51-100
Socials

Genevant Sciences Email Formats

Genevant Sciences uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@genevant.com), used 76.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@genevant.com	76.9%
{first initial}.{last name}	j.doe@genevant.com	23.1%

About Genevant Sciences

Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows us to maintain our leadership position in the space. • Best-in-class LNP + next generation ligand conjugate technologies • First and only FDA-approved siRNA-LNP utilizes Genevant technology • Nucleic acid payload design expertise • Several hundred patents worldwide • LNP technology evaluated in more than a dozen clinical programs, representing hundreds of subjects and patients • An established leader in delivery to the liver, now focusing capabilities on other tissues and cell types • Experienced team with deep technical expertise and a track record of innovation and creative corporate partnering

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Director

Senior

Employees by Department

Genevant Sciences has 17 employees across 9 departments.

Departments

Number of employees

Funding Data

Genevant Sciences has never raised funding before.

Genevant Sciences Tech Stack

Discover the technologies and tools that power Genevant Sciences's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Leaflet

Maps

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

MariaDB

Databases

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Bootstrap

UI frameworks

Unpkg

CDN

Yoast SEO

SEO

Frequently asked questions

Genevant Sciences is located in Vancouver, British Columbia, CA.

Genevant Sciences generates an estimated annual revenue of $4,705,525. This revenue figure reflects the company's market position and business performance in its industry.

Genevant Sciences has an estimated valuation of $15,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Genevant Sciences has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.